We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.64B
AUM Growth
+$69.3M
Cap. Flow
+$163M
Cap. Flow %
6.15%
Top 10 Hldgs %
15.9%
Holding
1,827
New
629
Increased
253
Reduced
185
Closed
664

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$46.9M
2
PBCT
People's United Financial Inc
PBCT
+$42.2M
3
MMM icon
3M
MMM
+$39.9M
4
LOW icon
Lowe's Companies
LOW
+$38.4M
5
EMR icon
Emerson Electric
EMR
+$35.8M

Top Sells

Rank Stock Value
1
EPAM icon
EPAM Systems
EPAM
+$40.2M
2
DHR icon
Danaher
DHR
+$37.9M
3
SO icon
Southern Company
SO
+$37.6M
4
KLAC icon
KLA
KLAC
+$33.8M
5
WFC icon
Wells Fargo
WFC
+$31.8M

Sector Composition

Rank Sector Weight
1 Technology 19.33%
2 Financials 16.14%
3 Industrials 11.04%
4 Consumer Discretionary 7.83%
5 Healthcare 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UPH
1151
DELISTED
UpHealth, Inc.
UPH
$55K ﹤0.01%
+4,680
New +$104K
SUNL
1152
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$54K ﹤0.01%
+535
New +$41.5K
ASXC
1153
DELISTED
Asensus Surgical, Inc.
ASXC
$36K ﹤0.01%
+58,100
New +$44.8K
SY
1154
So-Young International
SY
$198M
$35K ﹤0.01%
+17,480
New +$41.8K
SOLO
1155
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$31K ﹤0.01%
+14,400
New +$29.9K
CBAT icon
1156
CBAK Energy Technology Ltd
CBAT
$45.4M
$29K ﹤0.01%
+22,473
New +$28K
REVB icon
1157
Revelation Biosciences
REVB
$4.14M
– –
0
– –
SONM icon
1158
DNA X Inc
SONM
$4.75M
$21K ﹤0.01%
+139
New +$18.8K
VIVE
1159
DELISTED
VIVEVE MED INC
VIVE
$18K ﹤0.01%
+16,600
New +$16.6K
NUWE icon
1160
Nuwellis
NUWE
$183K
– –
0
– –
WORX
1161
DELISTED
SCWORX CORP NEW
WORX
$14K ﹤0.01%
+55
New +$13K
KPRX icon
1162
Kiora Pharmaceuticals
KPRX
$11.3M
$11K ﹤0.01%
+49
New +$12.8K
MTCR
1163
DELISTED
Metacrine, Inc. Common Stock
MTCR
$8K ﹤0.01%
+12,432
New +$6.52K
ABM icon
1164
ABM Industries
ABM
$2.84B
– –
-112,117
Closed -$4.58M
ABOS icon
1165
Acumen Pharmaceuticals
ABOS
$159M
– –
-77,152
Closed -$522K
ABSI icon
1166
Absci
ABSI
$1.28B
– –
-14,400
Closed -$118K
ACAD icon
1167
Acadia Pharmaceuticals
ACAD
$4.35B
– –
-26,637
Closed -$622K
ACGL icon
1168
Arch Capital
ACGL
$36.3B
– –
-33,037
Closed -$1.47M
ACHC icon
1169
Acadia Healthcare
ACHC
$2.99B
– –
-14,916
Closed -$905K
ACTG icon
1170
Acacia Research
ACTG
$447M
– –
-13,300
Closed -$68K
ADNT icon
1171
Adient
ADNT
$1.62B
– –
-5,731
Closed -$274K
AEP icon
1172
American Electric Power
AEP
$72.7B
– –
-4,206
Closed -$374K
AES icon
1173
AES
AES
$10.6B
– –
-21,965
Closed -$534K
AGI icon
1174
Alamos Gold
AGI
$12.5B
– –
-172,300
Closed -$1.32M
AGO icon
1175
Assured Guaranty
AGO
$3.78B
– –
-40,817
Closed -$2.05M
45 46
47
48 49

Similar funds

ROC
River Oaks Capital Wayzata, Minnesota $67.9M AUM 13.58% 1-Year Est. Return
IVMX
Institutional Venture Management XIV Menlo Park, California $67.7M AUM 8.12% 1-Year Est. Return
AM
Anqa Management Sag Harbor, New York $66.5M AUM 36.45% 1-Year Est. Return
JCG
John C. Goff $70.7M AUM 4.99% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
FA
Financial Advantage Columbia, Maryland $65.2M AUM 14.55% 1-Year Est. Return
VCM
Vetamer Capital Management Menlo Park, California $72M AUM 31% 1-Year Est. Return
MCMI
Matrix China Management IV Grand Cayman, Cayman Islands $64.3M AUM 53.64% 1-Year Est. Return

Ergoteles's Q1 2022 Portfolio in Review

As of Q1 2022, Ergoteles held 1,827 positions worth $2.64B, up 2.7% from $2.57B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ergoteles deployed $163M of net new capital in Q1 2022, opening 629 new positions and adding to 253 existing holdings. Its largest new stake was 3M: 299,716 shares worth $37.3M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Danaher, an estimated $37.9M trimmed.

  • Ergoteles's largest Q1 2022 buy was 3M: 299,716 shares worth $37.3M.
  • Ergoteles added most to Oracle in Q1 2022, an estimated $46.9M increase.
  • Ergoteles's biggest Q1 2022 reduction was Danaher, cutting an estimated $37.9M.
  • Ergoteles fully exited EPAM Systems in Q1 2022, selling an estimated $40.2M.
  • Ergoteles's ten largest holdings make up 16% of its $2.64B portfolio in Q1 2022.
  • Ergoteles opened 629 new positions and closed 664 in Q1 2022.
  • Ergoteles's portfolio value rose 2.7% quarter-over-quarter to $2.64B.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.